CARL logo

Carlsmed, Inc. Stock Price

NasdaqGS:CARL Community·US$432.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

CARL Share Price Performance

US$16.28
1.78 (12.28%)
US$16.28
1.78 (12.28%)
Price US$16.28

CARL Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with limited growth.

2 Risks
3 Rewards

Carlsmed, Inc. Key Details

US$44.8m

Revenue

US$11.3m

Cost of Revenue

US$33.5m

Gross Profit

US$59.8m

Other Expenses

-US$26.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.99
74.76%
-58.82%
14.5%
View Full Analysis

About CARL

Founded
2018
Employees
100
CEO
Michael Cordonnier
WebsiteView website
carlsmed.com

Carlsmed, Inc., a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Recent CARL News & Updates

Recent updates

No updates